GW&K Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $84K | Buy |
217
+30
| +16% | +$11.6K | ﹤0.01% | 441 |
|
2025
Q1 | $81K | Buy |
187
+20
| +12% | +$8.66K | ﹤0.01% | 426 |
|
2024
Q4 | $62K | Buy |
167
+3
| +2% | +$1.11K | ﹤0.01% | 444 |
|
2024
Q3 | $85K | Buy |
164
+7
| +4% | +$3.63K | ﹤0.01% | 407 |
|
2024
Q2 | $85K | Buy |
157
+27
| +21% | +$14.6K | ﹤0.01% | 397 |
|
2024
Q1 | $67K | Buy |
130
+60
| +86% | +$30.9K | ﹤0.01% | 402 |
|
2023
Q4 | $33K | Buy |
70
+4
| +6% | +$1.89K | ﹤0.01% | 447 |
|
2023
Q3 | $29K | Sell |
66
-4
| -6% | -$1.76K | ﹤0.01% | 445 |
|
2023
Q2 | $31K | Buy |
+70
| New | +$31K | ﹤0.01% | 421 |
|
2022
Q3 | – | Sell |
-24
| Closed | -$12K | – | 533 |
|
2022
Q2 | $12K | Buy |
24
+8
| +50% | +$4K | ﹤0.01% | 457 |
|
2022
Q1 | $8K | Buy |
+16
| New | +$8K | ﹤0.01% | 450 |
|